Navigation Links
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
Date:9/8/2009

sales of approximately $560 million.

About Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5%

Bepreve is a non-sedating, highly selective antagonist of the histamine (H1) receptor. It has a stabilizing effect on mast cells, and it suppresses the migration of eosinophils into inflamed tissues. The compound's primary mechanisms of action are believed to make it an effective treatment against ocular itching associated with allergic conjunctivitis.

Bepotastine was approved in Japan for use as a systemic drug in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively, and is marketed by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku Co., Ltd.) under the brand name TALION(R). TALION was co-developed by Tanabe Seiyaku and Ube Industries, Ltd., who discovered bepotastine. In 2001, Tanabe Seiyaku granted Senju Pharmaceutical Co., Ltd., exclusive worldwide rights, with the exception of certain Asian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the exclusive North American rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. In 2007, ISTA licensed exclusive North American rights to nasal dosage forms of bepotastine from Tanabe Seiyaku and obtained a future right to negotiate for a North American license to oral dosage forms of bepotastine for allergy treatment.

INDICATIONS AND USAGE

Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% is a histamine H1 receptor antagonist indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.

DOSAGE AND ADMINISTRATION

Instill one drop of Bepreve(TM) into the affected eye(s) twice a day (BID).

CONTRAINDICATIONS

None.

WARNINGS AND PRECA
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
7. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
8. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
9. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
10. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
11. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... and supplier of injectable drug delivery systems, today announced ... the Company,s Board of Directors has engaged Morgan Stanley ... alternatives to maximize shareholder value. Potential ... review process may include a possible sale of the ...
(Date:9/2/2015)... Simplified Genetics , the only provider of consumer marketed ... the U.S., announced today the launch of two groundbreaking genetic ... found within specific genes – all with a simple swab ... tests include Simply Fit and Simply Safe ... maps four key genes to provide individuals with the best ...
(Date:9/2/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co., Ltd. ("Guizhou Taibang") entered ... Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to ... to source no less than 500 tonnes of ...
Breaking Medicine Technology:Unilife Announces Review of Strategic Alternatives 2Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 2Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5
... HOLLYWOOD, Calif., July 28, 2011 IPC The Hospitalist Company, Inc. ... group practice, today announced financial results for the second quarter ... Highlights (comparisons are to second quarter 2010): ... net patient revenue growth of 20% Patient encounters ...
... Calif., July 28, 2011 Financial Highlights ($ in millions, ... Revenue , $110.6 , 20.2% increase Total Net Product ... , $60.3 , 27.5% increaseAldurazyme BioMarin Net Product Revenue* ... $28.8 , 16.6% increaseFirdapse Net Product Revenue , $3.2 ...
Cached Medicine Technology:IPC The Hospitalist Company Reports Second Quarter 2011 Results 2IPC The Hospitalist Company Reports Second Quarter 2011 Results 3IPC The Hospitalist Company Reports Second Quarter 2011 Results 4IPC The Hospitalist Company Reports Second Quarter 2011 Results 5IPC The Hospitalist Company Reports Second Quarter 2011 Results 6IPC The Hospitalist Company Reports Second Quarter 2011 Results 7IPC The Hospitalist Company Reports Second Quarter 2011 Results 8IPC The Hospitalist Company Reports Second Quarter 2011 Results 9IPC The Hospitalist Company Reports Second Quarter 2011 Results 10IPC The Hospitalist Company Reports Second Quarter 2011 Results 11BioMarin Announces Second Quarter 2011 Financial Results 2BioMarin Announces Second Quarter 2011 Financial Results 3BioMarin Announces Second Quarter 2011 Financial Results 4BioMarin Announces Second Quarter 2011 Financial Results 5BioMarin Announces Second Quarter 2011 Financial Results 6BioMarin Announces Second Quarter 2011 Financial Results 7BioMarin Announces Second Quarter 2011 Financial Results 8BioMarin Announces Second Quarter 2011 Financial Results 9BioMarin Announces Second Quarter 2011 Financial Results 10BioMarin Announces Second Quarter 2011 Financial Results 11BioMarin Announces Second Quarter 2011 Financial Results 12BioMarin Announces Second Quarter 2011 Financial Results 13
(Date:9/2/2015)... ... 2015 , ... Density measurement is used in many labs ... makes density measurements more efficient and error-free. The new METTLER TOLEDO video compares ... the advantages compared to manual sample handling. , The Evolution of Density Measurement ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... food banks in commemorating “Hunger Action Month” during the entire month of September. ... Food Bank will be dedicating its efforts this September to an awareness campaign ...
(Date:9/2/2015)... ... September 02, 2015 , ... A third party administrator ... after seeing a significant increase in unlawful tactics used by out-of-network (OON) ambulatory ... cases of OON ASCs encouraging members to have elective procedures done at their ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... engineer of patented products, announces Hand Free Pocket Cop, a safety invention that ... in the US is worth $31 billion," says Scott Cooper, CEO and Creative ...
(Date:9/2/2015)... ... 2015 , ... On September 9, 2015, over 27,000 people from all over ... convention to date for the state of Utah. , “We are thrilled with the ... David Stirling, doTERRA CEO. “One of the most exciting elements of our convention is ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2
... A North Carolina team of doctors, nurses, hospitals and ... way to provide faster, more effective treatment for heart ... or fancy new equipment. But it does require competitors ... to move treatment forward empowering emergency services personnel ...
... condition, which is symptomless, can lead to heart attack ... More American women are suffering from asymptomatic peripheral artery ... risk for heart attack and stroke, a new study ... of an increase in common cardiovascular risk factors, namely ...
... from union benefit funds,Union coalition says Rite Aid wants union money, but ... ... They are telling conference attendees: Trust Rite Aid? Think Twice!, ... pharmacy benefits management company (Rite Aid,Solutions) at the International Foundation Employee Benefits ...
... TARRYTOWN, N.Y., Nov. 3 EpiCept Corporation,(Nasdaq and OMX ... a,conference call to discuss third quarter 2007 results and ... 8:30 a.m. EST. EpiCept,will release results for the three ... EST on Monday, November 5, 2007. (Logo: ...
... is disappointed with today,s ruling and we intend to ... at issue was the result of,highly competitive conditions in ... ruling on liability is thus profoundly,anti- competitive. AstraZeneca ... drugs and we firmly believe that we have acted ...
... Mexican Red Cross for Flood,Relief, WASHINGTON, Nov. 2 ... to provide $50,000 to the Mexican Red Cross to,assist ... than,800,000 people. Unusually heavy rains caused rivers to overflow ... was already waterlogged,after Hurricanes Dean and Felix., "Thousands ...
Cached Medicine News:Health News:RACE: a statewide model of better, faster heart attack care 2Health News:RACE: a statewide model of better, faster heart attack care 3Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 2Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 3Health News:Rite Aid's Fledgling Benefits Management Firm Hits Turbulence at Employee Benefits Conference in Anaheim 2Health News:EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007 2Health News:EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007 3Health News:Sister Red Cross Societies Help Each Other 2
...
...
... At the entry-level, Philips Zymed 1810 Series ... preview, which gives the operator the flexibility ... complex arrhythmia. Choose an application beyond the ... flexibility. Select the interactive or automatic style ...
... Zymed 2010 plus Holter Software for ... application as easy to install, use ... data presentation as comprehensive as a ... superimposition, prospective paging and QuickScan, which ...
Medicine Products: